Cancer drugs cause large cells that resist treatment; scientist aims to stop it

Cancer drugs cause large cells that resist treatment; scientist aims to stop it
Human tumor lymphoma cells. Daruka Mahadevan, MD, PhD, a researcher at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, studies high-grade lymphoma and says many chemotherapies cause some cells to become large with more than two chromosomes. He said the goal is to introduce other drugs that stop this cell acquisition of extra chromosomes. Credit: National Cancer Institute

A cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes. Fueled by new genetic changes due to cancer therapy itself, these rogue cells are becoming very large with twice or quadruple the number of chromosomes found in healthy cells. Some of the cells may grow to eight, 16 or even 32 times the correct number. Quickly, they will become aggressive and resistant to treatment. They will eventually cause cancer recurrence.

Daruka Mahadevan, MD, Ph.D., professor and chief of the Division of Hematology-Oncology in the Long School of Medicine at UT Health San Antonio, has studied this progression for 20 years. In a paper published in April 2020 in the journal Trends in Cancer, he and co-author Gregory C. Rogers, Ph.D., explain a rationale for stopping it.

"When you give therapy, some cells don't die," explained Dr. Mahadevan, leader of hematology and medical oncology care at the Mays Cancer Center, home to UT Health San Antonio MD Anderson. "These cells don't die because they've acquired a double complement of the normal chromosomes plus other genetic changes. Many types of chemotherapy actually promote this."

Dr. Mahadevan found that two cancer-causing genes, called c-Myc and BCL2, are operative in "double-hit" high-grade lymphomas, which are incurable. "These genes are part of the problem, because when they are present, they help the lymphoma cells to live longer and prime them to become large cells with treatment," he said.

Although the drugs seem to be working, once therapy is stopped, the large (called tetraploid cells) start to divide again and become smaller but faster-growing cells, driven by c-Myc and BCL2.

"It's a double hit, a double whammy," Dr. Mahadevan said.

To counter this, Dr. Mahadevan seeks to find drugs that prevent or treat the rogue cells' acquisition of multiple chromosomes. He has identified a small-molecule inhibitor that shows promise in cell experiments in the laboratory. "We have data to show that it works," he said.

A drug that suppresses large with multiple copies of chromosomes could be used in combination with existing chemotherapies to prevent large cell resistance, not only in lymphoma but in many other types of , he said.


Explore further

Cancer researchers locate drivers of tumor resistance

More information: Daruka Mahadevan et al, Janus Face of Drug-Induced Tetraploidy in Non-Hodgkin Lymphoma, Trends in Cancer (2020). DOI: 10.1016/j.trecan.2020.03.009
Citation: Cancer drugs cause large cells that resist treatment; scientist aims to stop it (2020, May 28) retrieved 16 July 2020 from https://medicalxpress.com/news/2020-05-cancer-drugs-large-cells-resist.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
84 shares

Feedback to editors

User comments